Intellia Therapeutics, Inc. (NTLA) — Dilution Risk Analysis
Current Snapshot
Intellia Therapeutics, Inc. (NTLA) has a DilutionWatch score of 54/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 54/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
2 shelf registration or ATM offering filings detected in recent history.
Recent filing forms in the source payload: 8-K 1, 424B5 2, 4 7.
| Form | Filed | Accession |
|---|---|---|
| 8-K | 2026-04-30 | 0001193125-26-197489 |
| 424B5 | 2026-04-29 | 0001193125-26-192361 |
| 424B5 | 2026-04-27 | 0001193125-26-182419 |
| 4 | 2026-03-03 | 0001193125-26-088236 |
| 4 | 2026-03-03 | 0001193125-26-088241 |
| 4 | 2026-03-03 | 0001193125-26-088251 |
| 4 | 2026-03-03 | 0001193125-26-088254 |
| 4 | 2026-03-03 | 0001193125-26-088258 |
| 4 | 2026-03-03 | 0001193125-26-088260 |
| 4 | 2026-03-03 | 0001193125-26-088269 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| ATM offering capacity remaining | $180,000,010 | Source |
| Cash runway | 10 months | Source |
| Three-year share count growth | 56.47% | Source |
DilutionWatch Analysis
- Risk Level
- HIGH (Score: 54/10) Source
- Cash Runway
- 10 months Source
- ATM Offering Capacity Remaining
- $180,000,010 Source
- Share Count Growth (3-Year)
- 56.47% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.